Stock listing
NASDAQ:MACK Merrimack Pharmaceuticals Inc Stock
Follow Merrimack Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:MACK
$15.13 USD
Close on May 17, 2024 · No longer trades
- Lowest – highest close
- $1.63 – $15.13 USDSince Sep 6, 2017 · lowest Mar 20, 2020 · highest May 15, 2024
Delisted NASDAQ:MACK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MACK
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Merrimack Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Jan 9, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (January 2017) | Merger or acquisition | 26 slides | Jan 9, 2017 |
| Investor Presentation (September 2013) | Investor deck | 21 slides | Sep 9, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jean Franchi Other companies: Disc Medicine, Inc. (Chief Financial Officer · Since at least Feb 7, 2024); Biodesix, Inc. (Director · Since at least Oct 27, 2020); Replimune Group, Inc. (Chief Financial Officer · Dec 9, 2019 – May 16, 2023 · Past) | Chief Financial Officer · Feb 15, 2018 – Dec 11, 2018 · Past |
| John M. Dineen Other companies: Lam Research Corporation (President · Since at least Aug 24, 2023); Cognizant Technology Solutions Corporation (Director · Since at least Apr 1, 2017); Syneos Health Inc (Director · Dec 10, 2018 – Sep 28, 2023 · Past) | Director · Jun 15, 2015 – Jun 13, 2018 · Past |
| Richard Peters Other companies: Kineta Inc. (Director · Since at least Dec 22, 2020); Aprea Therapeutics, Inc. (Director · Since at least Jun 26, 2020) | President and CEO, Director · May 8, 2019 – May 8, 2019 · Past |
| Anthony J Sinskey Other companies: Metabolix Inc (Director · Nov 9, 2006 – Sep 10, 2015 · Past) | Director · Jan 31, 2012 – Dec 18, 2014 · Past |
| John Green Other companies: Cogent Biosciences, Inc. (Chief Financial Officer · Since at least Jan 31, 2019) | Principal Accounting Officer · Jun 14, 2017 – Jun 14, 2017 · Past |
| Noah G Levy Other companies: Inflection Point Acquisition Corp. III (Director · Apr 24, 2025 – Apr 24, 2025 · Past) | Director · Dec 30, 2022 – Jan 12, 2023 · Past |
| Robert C Gay Other companies: Angel Studios, Inc. (Director · Since at least Sep 10, 2025) | Director · Jan 31, 2012 – Apr 3, 2012 · Past |
| Sergio L Santillana Other companies: ImageneBio, Inc. (Chief Medical Officer · Mar 25, 2021 – Jan 3, 2023 · Past) | Chief Medical Officer · Jun 12, 2017 – Dec 11, 2018 · Past |
| Vivian S. Lee Other companies: Zions Bancorporation N.A. (Director · Since at least Mar 19, 2015) | Director · Nov 12, 2014 – Sep 13, 2017 · Past |
| Clet M Niyikiza | EVP of Development · Jan 31, 2012 – Mar 12, 2013 · Past |
All 17 people
| Person | Seat |
|---|---|
| Daryl C Drummond | Head of Research · Mar 31, 2017 – Dec 11, 2018 · Past |
| Edward J Stewart | Head of Commercial · Jul 15, 2015 – Jul 26, 2016 · Past |
| Gary L Crocker | See Remarks, Director · Jun 13, 2018 – Aug 10, 2023 · Past |
| John Mendelsohn | Director · Jun 13, 2012 – Sep 13, 2017 · Past |
| Thomas E Needham Jr | Chief Business Officer · Jul 24, 2017 – Aug 1, 2017 · Past |
| Ulrik B Nielsen | Director · Jun 10, 2021 – Jun 6, 2023 · Past |
| William M McClements | Head of Corporate Operations · Jan 31, 2012 – Feb 29, 2016 · Past |
Log in to ask 6ix AI your own questions about Merrimack Pharmaceuticals Inc.